Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477360
Status:
UNKNOWN
Last Update Posted:
2011-08-11
First Post:
2007-05-22
Brief Title:
Humeral Resurfacing Hemiarthroplasty
Sponsor:
University of Calgary
Organization:
University of Calgary
Study Overview
Official Title:
Humeral Resurfacing Hemiarthroplasty Phase 2 Prospective Cohort Study
Status:
UNKNOWN
Status Verified Date:
2011-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAP
Brief Summary:
The primary objective of this study is to examine quality of life outcomes in patients who have undergone a humeral surface replacement hemiarthroplasty
Detailed Description:
Resurfacing arthroplasty is gaining popularity for the reconstruction of advanced shoulder arthritis New generation re-surfacing prostheses are engineered to anatomically restore a smooth articulating surface to the humeral head while preserving bone stock and potentially minimizing the risk for diaphyseal fracture The results for shoulder resurfacing prostheses have largely been reported in retrospective reviews and have been very favorable The purpose of this multi-centered prospective study will be to determine the extent to which patient self-assessed outcomes American Shoulder and Elbow Society ASES Score following humeral resurfacing improve compared to pre-operative ASES scores
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None